Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Casticin is a flavonol isolated from A. annua, V. trifolia, and V. agnus-castus that decreases proliferation in K562, HL-60, and Kasumi-1 leukemia cell lines (IC50s = 5.95, 4.82, and 15.56 µM, respectively).1 It blocks TGF-β/SMAD signaling in LX2 cells preventing activation, inhibiting proliferation, and inducing apoptosis of these hepatic stellate cells.2 In a mouse model of liver fibrosis, casticin (20 mg/kg) decreases TGF-β1 mRNA and phosphorylated SMAD (p-SMAD) levels. Casticin induces apoptosis in hepatocellular carcinoma (HCC) and breast cancer cells.3,4 It also downregulates Twist and prevents the epithelial-mesenchymal transition (EMT) in human HCC SMMC-7721 cells.5
WARNING This product is not for human or veterinary use.
1. Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann. Hematol. 88(8), 743-752 (2009).
2. Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-
3. Casticin inhibits epithelial-
4. Casticin induces breast cancer cell apoptosis by inhibiting the expression of forkhead box protein M1. Oncol. Lett. 7(5), 1711-1717 (2014).
5. IκB kinase phosphorylation of SNAP-